Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
In the SURMOUNT-1 clinical trial, participants on the highest dose achieved 22.5% body weight reduction over 72 weeks
Then go deeper
A reduction in neonatal growth was also seen when liraglutide was used during lactation without having been used during pregnancy ( Supplement 3 )
Exercise, exercise, exercise
In parallel, Eli Lilly developed tirzepatide (Mounjaro)--a dual GLP-1 and GIP receptor agonist
And here is a detail that gets overlooked constantly: participants who received an initial starting dose of 4 mg experienced more GI symptoms than those who started at 2 mg
US$ 26.59
US$ 28.43
US$ 29.14
US$ 24.39
